2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide
C22H22ClN7O — CID 134177999
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide
2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide (PubChem CID 134177999) has the molecular formula C22H22ClN7O and a molecular weight of 435.92 g/mol. Its IUPAC name is 2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide.
Molecular Properties
| Compound Name | 2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide |
|---|---|
| PubChem CID | 134177999 |
| Molecular Formula | C22H22ClN7O |
| Molecular Weight | 435.92 g/mol |
| Exact Mass | 435.16 |
| IUPAC Name | 2-amino-N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(3-chloroquinolin-6-yl)methyl]imidazole-4-carboxamide |
| SMILES | Cc1cc(N)nc(C)c1CNC(=O)c1cn(Cc2ccc3ncc(Cl)cc3c2)c(N)n1 |
| InChI | InChI=1S/C22H22ClN7O/c1-12-5-20(24)28-13(2)17(12)9-27-21(31)19-11-30(22(25)29-19)10-14-3-4-18-15(6-14)7-16(23)8-26-18/h3-8,11H,9-10H2,1-2H3,(H2,24,28)(H2,25,29)(H,27,31) |
| InChIKey | SKQOIDQWNDVKDS-UHFFFAOYSA-N |
| XLogP | 3.24 |
| TPSA | 124.74 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 435.92 |
| LogP ≤ 5 | 3.24 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134177999 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.